The global recombinant proteins market is entering a decisive growth phase. Recombinant proteins have become foundational tools across modern biopharmaceutical development, powering everything from monoclonal antibody production to next-generation vaccines and cell & gene therapies. As biologics pipelines expand and research institutions push deeper into precision medicine, demand...